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INTRODUCTION: The primary aim of this study is to determine if orange juice (OJ) 
supplementation can attenuate cytokine (IL-6 and TNF-α) levels in human skeletal muscle 
following exercise in the heat. We hypothesized that exercise in a hot humid environment would 
increase IL-6 and TNF-α levels in skeletal muscle. Secondly we hypothesized that 
supplementation with 100% OJ would partially attenuate the cytokine response to exercise in a 
similar manner to carbohydrate-electrolyte beverage (CEB) but more so than just drinking water 
(W) following exercise. METHODS: In a single blind fashion, fourteen healthy males and four 
healthy females, consumed either 100% OJ, W, or a CEB for eleven days. Over five of those 
days they performed 80 minutes of intermittent cycling (4 sets of 15min at 70% max heart rate) 
in an environmental chamber set at a mild, thermal temperature (30°C, 50% humidity). Muscle 
biopsies were taken from vastus lateralis on days 1, 4, 8, and 11 of the study and analyzed for 
the cytokines IL-6 and TNF-α via Western Blot protein immunoblotting technique. RESULTS: 
There was no main effect for either time or group for IL-6 in skeletal muscle. However, there 
was a group x time interaction (p=0.018), where the group that consumed W linearly increased 
from day 1 to day 11 while the OJ, and CEB groups did not change. TNF-α skeletal muscle 
levels were below the detection level of the imaging system and were not analyzed statistically. 
DISCUSSION: In conclusion, there was significant group times time interaction in the W group 
but not the CEB or OJ groups However, our data does suggest that the carbohydrate content of 
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Inflammation in the body can occur with conditions such as fever or tissue damage, and also with chronic 
inflammation associated with diseases such as cancer, cardiovascular disease and Type 2 diabetes 
(Petersen & Pedersen, 2005). Indicators of inflammation include small proteins called cytokines such as 
interleukin-6 (IL-6) and tumor necrosis factor- α (TNF-α). Broad ranges of tissues are capable of 
producing cytokines. These tissues include but are not limited to; leukocytes, skeletal muscle, adipose 
tissue, and endothelial cells, (C. P. Fischer, 2006). Cytokines act in the acute phase response as signaling 
molecules. There they aid in the regulation of immune system activity. In recent years, skeletal muscle has 
been found to possess the ability to function as an endocrine organ that can secrete cytokines that act in a 
fashion separate from the traditional acute phase response (Munoz-Canoves, Scheele, Pedersen, & Serrano, 
2013). 
In the acute phase response TNF-α is amongst the first to appear in the cytokine cascade (Petersen & 
Pedersen, 2005).  When pro-inflammatory cytokines TNF-α and IL-β are released, IL-6 production is 
stimulated, which can then act in a pleiotropic manner (Nieman, 2000). The pro-inflammatory function of 
IL-6 is to induce the acute phase response proteins that aid the immune system in recognizing foreign 
bodies and dying cells to prevent infection. When levels of pro-inflammatory cytokines, interleukin-1 (IL-
1) and TNF- α, get too high IL-6 shifts into an anti-inflammatory role by stimulating the release of IL-
receptor antagonist (IL-1ra). IL-1ra, another anti-inflammatory cytokine, acts to inhibit the activity of the 
pro-inflammatory IL-1. This pathway is also known as the classical cytokine response. In this way these 
cytokines regulate inflammation and the removal and repair of damaged tissue (Nieman, 2000) . 
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The ability of active skeletal muscle to produce cytokines, or myokines as they are known when secreted 
by muscle, has become a widely accepted theory and one that appears to be independent of the classical 
cytokine response (Bente K. Pedersen & Febbraio, 2008). This stems from the observation that TNF-α 
levels do not always increase significantly with exercise while IL-6 production does increase to a 
significant degree (Petersen & Pedersen, 2005). Therefore, if vigorous exercise can alter cellular 
homeostasis enough to induce cytokine activity it then provides a prime avenue for studying exercise-
induced inflammation (Brenner et al., 1999). 
Researchers have also suggested that exercise induces gastrointestinal endotoxemia. Increased 
permeability of the gastrointestinal endothelial wall caused by reduced blood and oxygen flow during 
exercise can cause what is termed as “leaky gut”. A “leaky gut” enables gastrointestinal pathogens or 
endotoxins to cross the wall of the gastrointestinal tract and enter the bloodstream, that then leads to an 
acute phase response and cytokine production (Mach & Fuster-Botella, 2017). Considering the “leaky gut” 
theory, there is a degree of debate as to the source of cytokine production during exercise, regardless of 
whether the measures are from the analysis of blood, muscles, or other tissue. Although this theory 
presents a conflicting source of cytokines during exercise, there is a bulk of research that supports the 
production of cytokines via active skeletal muscle (R. L. Starkie, Hargreaves, Rolland, & Febbraio, 2005) .  
Many factors can influence the degree of cytokine release and manipulation of some of those factors can 
lead to novel ways of reducing post-exercise inflammation. Environmental factors, specifically high heat 
and humidity, can significantly increase cytokine activity during and post-exercise (Cosio-Lima, Desai, 
Schuler, Keck, & Scheeler, 2011). Conversely, nutritional intake has shown promise in reducing markers 
of inflammation. Supplementation with carbohydrates and the antioxidant ascorbic acid (vitamin C) can 
possibly aid in attenuating cytokine activity after exercise (Christian P. Fischer et al., 2004; R. L. Starkie, 
Arkinstall, Koukoulas, Hawley, & Febbraio, 2001). There is little research however on the ability of 
ascorbic acid supplementation to attenuate cytokine activity after repeated exercise in a hot environment. 
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Much exercise induced cytokine literature is conducted over one or two exercise bouts, with IL-6 measures 
taken from blood samples. This leaves a lack of research investigating the activity of cytokines within 
skeletal muscle, where it can be produced, over multiple exercise sessions. Therefore, the focus of this 
investigation was the influence that exercise, hot environment, and carbohydrate and ascorbic acid 
supplementation have on IL-6 and TNF- α levels in active skeletal muscle.  
Statement of the Problem 
The nutritional properties of 100% orange juice (OJ) may provide health benefits to physically active 
individuals recovering from intense exercise. Compared to standard commercially available carbohydrate-
electrolyte beverages (CEB), 100% OJ provides a similar carbohydrate profile, has less sodium, more 
potassium and other vitamin and minerals such as ascorbic acid, a known antioxidant. Few research studies 
have investigated the effects of 100% OJ on markers of inflammation following acute intense exercise in 
the heat or over consecutive exercise days.  
Specific Aim and Hypotheses 
The primary aim of this study is to determine if OJ supplementation can attenuate cytokine levels in human 
skeletal muscle following exercise in the heat. 
Hypothesis1.1. Exercise in a hot humid environment would increase IL-6 and TNF- α levels in 
skeletal muscle. 
Hypothesis1.2. Supplementation with 100% orange juice (OJ) (83.6 mg ascorbic acid /8 fl oz) 
would result in greater attenuation of increases in markers of inflammation in skeletal muscle 
compared to just drinking water (W) but would have similar results to supplementation with a 





Review of Literature 
Introduction 
IL-6 and TNF-α are cytokines that can be stimulated wherever inflammation or damage occurs in the body. 
It has also been established that vigorous exercise and can induce cytokine activity and inflammation 
(Brenner et al., 1999; Petersen & Pedersen, 2005). Overtime as the body adapts to training the rise in 
cytokines can be attenuated as regular exercise is  known to decrease inflammation and protect the body 
against chronic inflammatory diseases (Petersen & Pedersen, 2005). Exercise bouts in environmental 
extremes, specifically high heat and humidity, have significant effects on cytokine activity (Cosio-Lima et 
al., 2011). There are a number of emerging interventions that show promise in combating inflammation 
following exercise in the heat. Supplementation with carbohydrates and the antioxidant ascorbic acid can 
aid in attenuating cytokine activity after exercise (Christian P. Fischer et al., 2004; R. L. Starkie et al., 
2001). Therefore, the focus of this literature review is on the influence of exercise, hot environment, and 
carbohydrate and ascorbic acid supplementation on IL-6 and TNF- α levels in active skeletal muscle. 
Tumor Necrosis Factor-α  
TNF-α is one of the first cytokines produced in response to exercise induced injury or damage and takes 
part in the acute phase response. Various tissues in the body can produce this signaling protein, anywhere 
cell damage may occur. TNF-α can spearhead a cascade of cytokine activity that is part of the acute phase 
response to injury or infection and can induce the release of IL-6 (Nieman, 2000).  
TNF-α and Exercise 
TNF-α has a pro-inflammatory role in exercise and is linked with muscle catabolism (Goodman, 1991). 
TNF-α presence in contracting muscle varies in the literature. Compared to the IL-6 response to exercise, 
TNF-α does not increase nearly as much but it has been shown to be present in muscle (Petersen & 
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Pedersen, 2005). The degree of increase may depend on modality and intensity of exercise, with greater 
intensities yielding greater increases. Also of note, much research presents TNF-α mRNA measures, but 
does not include TNF-α protein measures from biopsies. Though gene expression does not directly reflect 
the production of this cytokine, it can still provide insights into its role in exercise. 
TNF-α activity in muscle has been investigated after 40 trained male cyclists participated in a three-week 
double-blind study. Over three days of the study, they cycled for 3 hours each at 57% max effort. The 
cyclists were split up into two groups. The experimental group consumed the antioxidant quercetin for 
three weeks, and the control group consumed a placebo over the same time period. Blood samples and 
muscle biopsy samples were collected. Analysis of the plasma cytokines after the cycling sessions showed 
significant increases of cytokines, including TNF-α, in the control group. There was a less significant 
increase in the quercetin group. TNF-α mRNA expression in biopsy tissue was significantly increased after 
cycling in both supplement groups (Nieman et al., 2007). This study demonstrates that significant increases 
in TNF-α mRNA can occur following endurance exercise. 
In an opposing study, six males performed two legged knee extensor exercises at 55% of their 1 RM for 
180 minutes. Blood and muscle tissue samples were obtained pre exercise and at 30, 90, and 180 minutes 
during the exercise trial. There was no significant increase found in TNF-α mRNA expression from the 
blood or muscle tissue during the exercise (A. Steensberg et al., 2002). It was concluded that there was no 
significant TNF-α production in skeletal muscle during this exercise. This study admittedly did not analyze 
TNF-α protein and did not take post measures to see if the acute phase reaction took place after exercise, 
which according to the previous study cited, is when TNF-α expression occurred.  
The time course of TNF-α release and production should be considered when studying the effects of 
exercise on cytokine production. For example immediately after running a marathon no changes were 
observed in TNF-α mRNA expression in muscle biopsies or blood mononuclear cells, but a significant 
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difference was measured 2 hours post-race in TNF-α plasma concentrations (Ostrowski, Rohde, Zacho, 
Asp, & Pedersen, 1998). 
These studies further highlight the importance of post-exercise data collection points. TNF-α mRNA 
significantly increased in biopsies taken immediately post and 2, 12, and 24 hours after 30 min of running 
at 75% max O2 uptake, peaking around the 12 hour mark with a 4.5-fold increase from baseline. After a 
bout of resistance exercise consisting of 3 sets of 10 knee extensions at 70% 1RM, TNF- α mRNA was 
significantly increased immediately, and at 2, 4, 8, and 24 hours post, peaking in the 8 hour biopsy with a 
6.3-fold increase from baseline (Louis, Raue, Yang, Jemiolo, & Trappe, 2007).  
It appears that when investigating TNF-α after exercise, measures should be monitored at least 2 hours post 
and even up to 12 hours post-exercise. The lack of extended post-exercise measurements in some literature 
could partly explain the variance in findings concerning TNF-α in muscle. Further research with extended 
time point post-exercise biopsies and actual intramuscular TNF-α protein measures will be needed to 
explore this cytokine further.  
TNF-α and Exercise in Heat 
Exercise in hot environments also appears to alter TNF-α concentration. In a crossover study, 6 elite male 
cyclists (VO2 max =66±6 mL/kg/min) took part in two training rides at 60% max wattage and 75% VO2 
max for 2.5 hours. One ride at 15˚C and 40% humidity and the other at 35˚C and 40% humidity. The two 
rides were separated by a week. TNF-α concentration in blood plasma did not change significantly in the 
neutral condition ride (15˚C) or post-ride. No significant change in TNF-α was observed during the ride in 
hot (35˚C) conditions but levels did increase significantly post-ride and up to 12 hours post-ride in the hot 
(35˚C) condition  (Cosio-Lima et al., 2011). Thus, it appears that exercise in the heat and humidity 
increases TNF-α production post-exercise and extends the time over which it remains significantly 
elevated. It is worth noting that the small sample size as well as the training status of these subjects were 
two variables that could have affected the release of cytokines in this particular study. 
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Interleukin-6 
IL-6 is a cytokine which can be stimulated wherever inflammation or damage occurs in the body. IL-6 acts 
in either a pro or anti-inflammatory manner dependent on site of production. Its main pro-inflammatory 
function is to induce the acute phase response, which releases acute phase proteins into the blood stream 
that aid the immune system in recognizing foreign bodies or dying cells to prevent infection (C. P. Fischer, 
2006). As an anti-inflammatory cytokine, IL-6 stimulates the release of IL-1ra, which inhibits the pro-
inflammatory IL-1. In this way, IL-6 can regulate anti-inflammatory and pro-inflammatory pathways 
(Nieman, 2000). IL-6 is also known as a myokine, meaning it is a cytokine that is produced by and acts on 
skeletal muscle (Munoz-Canoves et al., 2013). It is has pleiotropic functions and is capable of playing a 
hormonal role in muscle metabolism as well as effecting muscle function (Plomgaard, Penkowa, & 
Pedersen, 2005). 
IL-6 Production during Exercise 
Levels of IL-6 increase within skeletal muscles during and after prolonged training bouts and competitions 
such as marathon racing (C. P. Fischer, 2006; Nieman et al., 2001). An increase in intermuscular IL-6 
mRNA can also occur after as little as 30 minutes of exercise (A. Steensberg et al., 2002). These increases 
have been reported to be anywhere from 5 fold that of circulating plasma levels, up to extreme 100-fold 
increases following extended endurance runs (C. P. Fischer, 2006). As for IL-6 protein, 
immunohistochemical analysis after 3hr of cycling at 60% VO2 max showed that IL-6 levels in muscle 
tissue was significantly elevated post exercise and remained significant for 6 hours post (Penkowa, Keller, 
Keller, Jauffred, & Pedersen, 2003). 
Adaptations to training result in a decrease in the basal plasma levels of IL-6 but significant increases in 
circulating levels of this cytokine are still induced after a single training bout. Despite a basal decrease of 
IL-6 protein in response to training, muscular levels of IL-6mRNA increase. This increase possibly leading 
to a heightened sensitivity to and greater capability of IL-6 protein production if needed (C. P. Fischer, 
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2006). During exercise, skeletal muscle can be the primary producer of IL-6. A study investigating the 
effects of the immune response after exercise found that circulating IL-6 protein levels rose in response to 
90 minute cycling bouts at 70% VO2 max in both a heated and control condition. However, flow cytometry 
demonstrated that circulating monocytes were not the source of IL-6 production in either condition. This 
lead the researchers to conclude that IL-6 was being released primarily from contractile skeletal muscle (R. 
L. Starkie et al., 2005).  
As for the time course of IL-6 release, it was observed that after a 30 minute run at 75% max O2 uptake IL-
6 mRNA from skeletal muscle was increased from baseline immediately post, and at 4, 8, 12, and 24 hours 
post, peaking between 4 and 12 hours with up to a 187-fold increase. After 3 sets of 10 knee extensions at 
70% 1RM, mRNA was significantly elevated from 4-24 hours post-exercise with a peak 791-fold increase 
occurring at 4 hours post (Louis et al., 2007). Regardless, this study highlights that even though these 
increases may be extreme, IL-6 protein levels rise much more so than TNF-α after exercise. When 
measuring both IL-6 mRNA and IL-6 protein from muscle biopsies post exercise it was found that IL-6 
mRNA peaked immediately post exercise and leveled off by the 6 hour post biopsy. As for IL-6 protein 
from the same study, levels increased significantly post exercise and remained significant 1.5, 3, and 6 
hours post but had decreased to non-significance by 24 hours post exercise (Penkowa et al., 2003). Another 
point of interest is the value of taking biopsies at post-exercise time points in order to measure the peak 
values of cytokine reactions to exercise. This is important because it seems that maximal IL-6 levels are 
often observable immediately after exercise and rapidly decrease with a half-life of 1-2 hours (B. K. 
Pedersen, 2000). 
The skeletal muscle production of IL-6 protein during exercise is actually separate from the traditional 
acute phase response and is independent of TNF-α stimulation (Munoz-Canoves et al., 2013). In fact in 
exercise it can play an anti-inflammatory role, as mentioned, by inhibiting TNF-α and stimulating the 
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release of other anti-inflammatory cytokines (Petersen & Pedersen, 2005). This possibly partially explains 
why non-significant changes or even dampened levels of TNF-α in skeletal muscle are seen in literature. 
IL-6 and Exercise Modality 
Exercise modality can determine the degree to which cytokines and the immune system become active 
during and following physical activity. When comparing maximal anaerobic exercise (5 minutes of cycling 
at 90% VO2 max), circuit training (three sets of ten at 60-70% 1-RM for bicep curl, knee extension, 
hamstring curl, bench press, and leg press), 2 hours of cycling at 60-65% VO2 max, and 5 hours of rest in a 
randomized block design, it was found that only the 2 hours of cycling produced significant changes in 
plasma IL-6 levels (Brenner et al., 1999). Furthermore, after high intensity resistance activities, IL-6 may 
not peak until 1-1.5 hours post-exercise whereas following prolonged endurance exercise IL-6 levels can 
reach peak values immediately post-exercise (B. K. Pedersen, 2000). Thus, timing of measurement and 
exercise modality should certainly be considerations when investigating IL-6 activity.  
While prolonged endurance exercise elicits the greatest response of plasma and muscular IL-6, running in 
particular can exhibit the greatest response in comparison to cycling, swimming, or rowing (Nieman et al., 
1998). One possible explanation could be the greater amount of muscle mass utilized and that other 
endurance sports have little to no eccentric component that would produce greater muscle damage. 
Duration of exercise, regardless of modality is one of the greatest factors in determining the IL-6 response 
to exercise, accounting for more than 50% of variance in observed levels of IL-6 (Fischer, 2006).  
IL-6 and Exercise in Heat 
Research regarding IL-6 response to exercise in heat contains discrepancies as to whether or not heated 
environmental conditions cause an increase in IL-6 levels. As skeletal muscle produces heat with 
contraction, and especially as excessive external temperatures increase heat stress during exercise, heat 
shock factors 1 and 2 (HSF1 and HSF2) can induce production of IL-6 (Pritts et al., 2002). 
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For example, cycling in heat (35˚C) does not significantly affect monocyte production of IL-6 but it can 
stimulate a 4 fold increase in plasma circulating IL-6 versus cycling in control (15˚C) suggesting an 
intramuscular release of the cytokine (R. L. Starkie et al., 2005). This was supported by a study in which 8 
trained males cycled for 60 minutes in 20˚C (CON) and 35 ˚C (HOT) settings at 70% VO2 max. Plasma IL-
6 levels in the HOT trial were almost double those from the CON trial at 30 minutes of exercise, 60 
minutes of exercise, and 30 minutes post exercise showing a significant effect for condition (Mundel, 
Jaime, & Jones, 2010) 
In a crossover study, 6 elite male cyclists took part in 2 training rides at 60% max wattage and 75% VO2 
max for 2.5 hours. One ride took place in an environmental chamber at 15˚C, 40% humidity, the other at 
35˚C, and 40% humidity. The two rides being separated by a week. IL-6 plasma levels were significantly 
increased post-ride in the neutral (15˚C) and hot (35˚C) conditions and remained significantly increased at 
12 hours post-ride in the hot (35˚C) condition (Cosio-Lima et al., 2011). Although there was a significant 
main effect for time (P=0.003) there was not a significant main effect for conditions (P=0.481). Similar 
results were found in 7 endurance athletes after running at 90% velocity of anaerobic threshold for 60 
minutes in both 18˚C/50% humidity and 28 ˚C/50% humidity. No differences in IL-6 plasmas levels were 
detected between the two tests, therefore environment did not influence IL6 production (Niess et al., 2003) 
Furthermore, eleven recreationally trained males cycled for 1 hour in three separate conditions: hot (33 
˚C), cold (7˚C), and temperate (20˚C). Blood draws were taken pre-exercise, post-exercise, and 3 hours 
post-exercise to measure IL-6 plasma concentration. Again no significance was found across 
environmental conditions (p=0.207). Core temperatures were also taken during this study and there was no 
significant changes seen across conditions (E Dinan et al., 2017) 
Further research is needed to elucidate whether or not environmental conditions are a consistent stimulus 
of IL-6 production. It should be noted that many of these studies contain small subject pools. All of the 
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above studies provide blood plasma data and there is a lack of research in which IL-6 in muscle tissue is 
examined during and after exercise in the heat.  
IL-6 and Carbohydrate Supplementation 
Substrate availability and in particular muscle glycogen stores affect IL-6 release. The relationship 
between glycogen levels and skeletal muscle IL-6 production is inverse. In other words, the more 
intramuscular glycogen depletion that occurs during exercise the greater the muscular production of IL-6 
(Adam Steensberg et al., 2001). Furthermore, carbohydrate ingestion attenuates plasma levels of IL-6 post-
exercise in both running and cycling when compared to no carbohydrate consumption (R. L. Starkie et al., 
2001). In that study, intramuscular levels of IL-6 mRNA remained unchanged but due to carbohydrate 
ingestion, circulating plasma levels of IL-6 decreased.  
This could be due to the proposed glucoregulatory function of IL-6. Cultured rat hepatocytes increased 
glucose release when exposed to IL-6 (Ritchie, 1990). IL-6 not only increases hepatic glucose release but 
can lead to the uptake of glucose via translocation of GLUT4 to cellular plasma membranes for increased 
insulin-stimulated glucose uptake (Munoz-Canoves et al., 2013). If blood glucose or muscle glycogen 
levels are not an issue after vigorous exercise, then IL-6 may not need to perform this function, providing a 
possible explanation for the decrease in plasma IL-6 in the Starkie et al. study mentioned previously.  
This finding is confirmed in other exercise studies as well. During 2.5 hours of cycling or running subjects 
consumed either a 6% carbohydrate beverage every 15 minute or a placebo beverage. Blood samples were 
taken pre, immediately post, 1-hour post, 3 hours post, and 6 hours post-exercise. IL-6 levels in the blood 
plasmas were attenuated in the carbohydrate group in both the cycling and running modalities when 
compared to the placebo group (Nieman et al., 1998). Based on these results and the results of the above 
studies it would appear that supplementation with carbohydrates or adequate carbohydrate fueling helps to 
attenuate cytokine production and inflammation from exercise. 
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As mentioned, it could be that IL-6 has some glucoregulatory role in the body.  IL-6 levels are higher when 
glycogen depletion occurs and attenuated when subjects are in a glycogen fed state. When glycogen levels 
become exhausted, AMP-activated protein kinase (AMPK) can trigger glucose uptake. The relationship 
between IL-6 and AMPK has been demonstrated but the mechanisms behind it have yet to be elucidated.  
For example, increases in IL-6 correlate with increase in AMPK, which regulates cellular energy 
homeostasis. This correlation was made apparent when both IL-6 and AMPK levels rose similarly in 
subjects during a 60-min trial on a bicycle ergometer at 70% VO2 max while in a glycogen depleted state. 
Measurements were taken via muscle biopsies performed pre-exercise, and at the 10 and 60 minute mark 
of exercise. Blood draws occurred at 10, 20, 30, 45 and 60 minutes of exercise. When this bicycle 
ergometer protocol was repeated a second time with subjects in a glycogen loaded state both IL-6 and 
AMPK increases were attenuated (MacDonald, Wojtaszewski, Pedersen, Kiens, & Richter, 2003).  
This relationship has been further examined in rat skeletal muscle. Both in vitro experiments with extensor 
digitorum longus and in vivo experiments with rat gastrocnemius, significantly increased α2AMPK 
activity after incubation in 120ng/ml of IL-6 for 15 minutes and injection with 25ng/g of IL-6 for 60min 
respectively (Kelly, Gauthier, Saha, & Ruderman, 2009). Thus, they observed that when IL-6 was 
introduced to the muscle there was an increase in AMPK activity. The same researchers also conducted a 
study in which IL-6 gene knockout mice and control mice were split evenly so that half of each group 
remained sedentary and the other half performed a 60-minute swim. Analysis of the gastrocnemius found 
that the level of phosphorylated AMPK was significantly blunted in the knockout group after the exercise 
when compared to the control group (Kelly et al., 2004). It appears that during or after exercise when 
glycogen is needed, IL-6 could activate AMPK that would in turn promote glucose uptake by active 
skeletal muscle. 
These findings suggest that IL-6 can play an anti-inflammatory glucoregulatory role. Furthermore, it 
implies that carbohydrate fueling status has an effect on exercise-induced inflammation. Proper 
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carbohydrate supplementation prior to and during exercise could act as a safe guard against fuel depletion 
via muscle glycogen regulation and further preventing inflammation and muscle damage. 
IL-6 and Ascorbic Acid Supplementation  
Antioxidants, specifically ascorbic acid, may blunt the release of IL-6 post-exercise. However, the results 
from research investigating IL-6 activity after ascorbic acid supplementation have provided mixed 
conclusions.  
Ascorbic acid  supplementation over 4 weeks resulted in no significant change in IL-6 protein or IL-6 
mRNA expression in muscle biopsy but did inhibit the translocation of  IL-6 from skeletal muscle into 
circulation and reduced plasma IL-6 by 50%  (Christian P. Fischer et al., 2004).  
Another study split ultra-marathoners into an experimental ascorbic acid supplementation group and a 
control group. The experimental group supplemented with ascorbic acid for a week prior to a 48-80km 
race and received a carbohydrate-ascorbic acid drink during the race. The control group did not receive 
anything throughout the study. After analysis, there was no significant correlation between post-race 
plasma ascorbic acid and immune measures including IL-6 (Nieman et al., 2002). It should be noted that 
the carbohydrates in the drink mix might have effected IL-6 production as well.  
Similar findings came from a 4-month supplementation study that included 3 months of cycle training 5 
days a week. Twenty-one healthy males were split into a vitamin supplementation group (n=11) and a 
placebo group (n=10). The vitamin group ingested 500mg ascorbic acid and 400 IU vitamin E tablets daily 
for 16 weeks. After one month of supplementation, the cycle training commenced and lasted the final 12 
weeks of supplementation. One-hour cycle ergometer tests were performed at 65% max power pre and 
post-training. No significant differences were found in IL-6 plasma or muscle IL-6 mRNA levels between 
groups (Yfanti et al., 2012). After 4 months of supplementation, ascorbic acid did not have an effect on 
exercise-induced increases in IL-6 levels in blood or muscle. 
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Contrary to the previous studies, the plasma IL-6 response to 45 minutes of cycling at 70% VO2 max was 
significantly blunted after 15 days of 1000mg ascorbic acid supplementation. Six healthy untrained males 
preformed two 42 minute cycling tests pre and post 15 days of vitamin supplementation (Vassilakopoulos 
et al., 2003). Training status could have played a role in these findings when compared to the literature 
mentioned above. This shows though that as an antioxidant ascorbic acid may be able to reduce 
inflammation in untrained individuals after exercise. 
With multiple findings, more research will have to be conducted to determine the interaction between 
ascorbic acid and IL-6. Factors such as training status, timing of supplementation and dosage may alter 
whether or not ascorbic acid is beneficial for reducing exercise-induced inflammation.   
The research reviewed here administered daily doses of 500-1000mg whereas 8 oz of 100% orange juice 
contains 83.6 mg of ascorbic acid  (USDA, 2016). The recommended daily allowance of ascorbic acid  for 
persons 19 and older is 90mg for males and 75mg for females (Medicine, 2000). Ingestion of 30–180 
mg/day of ascorbic acid results in an absorption rate of 70%–90%. However, this rate falls to less than 
50% absorption when the dosages are increased above 1 g/day (Jacob & Sotoudeh, 2002). When 
comparing a high dosage supplementation regime with normal ascorbic acid-rich food consumption it was 
observed that oral ingestion of 1.25 g/day ascorbic acid  results in plasma ascorbic acid concentrations that 
were nearly two times higher than those produced by consuming 200–300 mg/day ascorbic acid from 










Fourteen male and four female subjects (male: age= 22 ± 3 yrs., weight= 74.16 ± 8.72 kg, height= 175.74 
± 6.76 cm; female: age= 23 ± 5 yrs., weight= 65.95 ± 13 kg, height= 169.28 ± 9.975 cm) volunteered to 
participate in this study. Participants were moderately endurance trained (running 3 days/week minimum) 
and recruited from The University of Kansas and surrounding community. Inclusion criteria was defined as 
having good general health, and accepted based upon the absence of cardiovascular, respiratory, and 
metabolic disorders; musculoskeletal disorders preventing exercise; fluid or electrolyte balance disorders; 
and GI or swallowing disorders. Female participants were scheduled according to menstruation to limit 
variances in hormone, body temperature, and the inflammatory process. It was also required that they have 
a VO2max equal to or greater than 40 ml · kg-1 · min-1 for males and equal to or greater than 38 ml · kg-1 
· min-1 for females (male: VO2max= 49.99 ± 7.02; female VO2max= 44.6 ± 7.45). This study was 
submitted for approval and accepted by the University Institutional Review Board for the protection of 
human subjects, and all participants were required to complete a health history questionnaire and sign an 
informed consent document. 
Research Design 
A randomized controlled, single blind design was utilized to determine the effects of 100% orange juice on 
the following dependent variables: IL-6, and TNF-α. This took place over 11 days of daily beverage 
supplementation and 5 consecutive days of repeated cycle ergometer bouts. Independent variables were OJ 
(237ml [8 oz] of 100% OJ/day), CEB (237ml of CEB/day), and W (237ml of W/day). OJ contained 83.6 
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mg of ascorbic acid /8 fl oz (USDA, 2016) (Figure 1). All experimental trials took place in a mild thermal 
environment (30°C, 50% humidity). 
Figure 1 
Nutritional Information  
 
(Co., 2018; USDA, 2016) 
Study Design 
Participants reported Day 1 for baseline testing (muscle biopsy). Participants were provided take home 
instructions and, 3 bottles containing 237 ml each of assigned beverage to consume on Days 1 – 3. Prior to 
arriving for each exercise day (Days 4 - 8), participants were instructed to consume a small meal and report 
euhydrated. Euhydration was defined as a plasma osmolality (Posm) < 290 mOsmols or urine specific 
gravity (Usg) < 1.020.6. Upon completing post-exercise measures, participants consumed 237 ml of 
assigned beverage and rested for 1 hr in a thermoneutral environment. Prior to leaving the laboratory on 
Day 8, participants were given Take Home Instructions and 3 bottles containing 237 ml each of assigned 
beverage to consume on Days 9 - 11. Final muscle biopsies were taken Day 11 (Figure 2). 
 
 Carbohydrate Electrlyte Beverage  Orange juice
Nutrient Unit 8 fl oz = 248.8g Nutrient Unit 8 fl oz = 248.8g
Total lipid (fat) g 0 Total lipid (fat) g 0.3
Carbohydrates g 14 Carbohydrates g 28.71
Sugars, total g 14 Sugars, total g 20.68
Protein g 0 Protein g 1.69
Minerals Minerals
Sodium, Na mg 100 Sodium, Na mg 5
Potassium, K mg 24 Potassium, K mg 443
Vitamins Vitamins
Niacin mg 4.5 Niacin mg 0.697
Vitamin B-6 mg 0.375 Vitamin B-6 mg 0.189
Vitamin B-12 µg 0.624 Vitamin B-12 µg 0















One week prior to the trial, subjects performed a graded exercise test to determine aerobic capacity or peak 
oxygen uptake (VO2max). A one-way, non-rebreathing respiratory valve and a nose clip were utilized to 
collect expired oxygen and carbon dioxide. A metabolic cart (True One 2400, Parvo Medics, Sandy, UT) 
was used to determine respiratory exchange ratio and oxygen consumption (VO2) values every 30 seconds 
while cycling (Excalibur 91900 V2.23, Lode B.V., Groningen, Netherlands). VO2max was determined when 
subjects attained a respiratory exchange ratio value > 1.10 and/or a VO2 increase from the previous 
exercise intensity of < 0.2 l/min. 
5 Day Exercise Protocol  
The exercise protocol was designed to induce muscle glycogen depletion and mild hypo-hydration to 
determine beverage effect on inflammation. On Days 4 - 8, participants performed 80 min of cycling 
exercise (Monark 818 E, Monark Exercise AB, Vonsbro, Sweden). The exercise consisted of a 2.5 minute 
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warmup and then four 15 min periods of intermittent cycling at 70% of max heart rate. In between each 15 
minute interval was a 5 minute interval during which subjects could cycle at a self-paced effort. Following 
the last 15 minute interval was a 2.5 minute cool down. The exercise protocol was conducted in an 
environmental chamber set at a mild, thermal temperature (30°C, 50% humidity). PArticpants were given 
1.5mk/kg body mass to drink during each of the 15 minute intervals. 
Measures of Muscle Inflammation  
Beverage effects on muscle inflammation was characterized using cytokines (TNF-α and IL-6). Skeletal 
muscle biopsies are taken Days 1, 4, 8, and 11 from the lateral aspect of the vastus lateralis by 
percutaneous needle biopsy (Bergstrom, 1962). Muscle samples were taken prior to exercise on the 
exercise protocol days (days 4 and 8). Samples were immediately placed in a       -20°C freezer for further 
analysis.  
Muscle Homogenization and Protein Quantification 
Proteins were extracted with a cocktail of cell extraction buffer protease inhibitor (Halt Protease Inhibitor; 
Thermo Scientific, Waltham, MA), phosphatase inhibitor (Halt Phosphatase Inhibitor; Thermo Scientific, 
Waltham, MA), and phenylmethylsulfonyl fluoride (PMSF) protease inhibitor (Nunc; Nalgene 
International, Rochester, NY). The muscle samples were placed in the solution, ground using a mortar and 
pestle, and then vortexed shortly every 10 minutes for 30 minutes then centrifuged at 3000rpm for 15 
minutes. Supernatant was removed and stored at -20°C until samples were measured for protein content 
with a BCA protein assay kit (Pierce BCA Protein Assay Kit; Pierce, Rockford, IL). (Aaron Graham, 
2010) 
SDS-PAGE 
Laemlli sample buffer was prepared and mixed 2:1 with dithiothreitol. Muscle homogenate protein (60 μg) 
was mixed with sample buffer and were vortexed, boiled for 5 min, vortexed again and then loaded into 
poly-acrylamide gels. Gels were run at a constant 250 V, 0.04 A, and in 1 × running buffer for 60–70 min 
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Western Blotting 
Proteins were transferred onto a PVDF membrane by wet transfer for 3 hours. The PVDF membranes were 
blocked for an hour using 5% milk blotto.  Primary antibodies were diluted 1:10,000 in 1% milk blotto 
(Cell Signaling, Danvers, MA, USA). The membranes incubated overnight at 4 °C with the primary 
antibody in a 1% milk blotto. The following day membranes were washed in TBS-T, then membranes were 
incubated with a secondary antibody and anti-biotin in a 1% milk TBS-T solution (Cell Signaling, 
Danvers, MA, USA) at a 1:1000 dilution for an hour. After rinsing membranes in TBS-T, they were 
incubated in a horseradish peroxidase chemilumenescent reagent for 5 minutes (Amersham, Piscataway, 
NJ, USA). Membranes were then imaged with a digital imaging system (Fluorchem HD2, ProteinSimple; 
San Jose, CA, USA or Amersham Imager 600, Amersham). Densitometry software (ImageQuant TL v8.1; 
Amersham) was used to quantify pixel brightness. 
Statistical Analysis 
A repeated measures analysis of variance (ANOVA) test was conducted to examin the main effects for 
time and markers of inflammation, as well as group interactions. A 3 x 4 group x time ANOVA was used. 
The independent variable, the beverage group, was made up of 3 levels: OJ, W, and CEB. The dependent 
variables were intramuscular cytokines measures and time. Then a one way ANOVA was conducted for 
each beverage group to determine any significant differences between each day within a group. 










A repeated measures ANOVA was used to examine the differences in IL-6 within skeletal muscle between 
three groups and across four time points: OJ, W, and CEB groups, as well as time points Day 1, 4, 8, and 
11 during the exercise protocol (Figure 3). 
 




The was no main effect for time or group for IL-6 in skeletal muscle. However, there was a group x time 
interaction (p=0.018), where the IL-6 levels of the W group increased linearly from day 1 to day 11 while 
the OJ, and CEB groups remained unchanged (Figure 4). Post-hoc independent T-tests found a significant 








TNF- α Measures 
TNF-α skeletal muscle levels were below the detection level of the imaging system and were not analyzed 
statistically (Figure 5).  
Figure 5 






The aim of the present study was to determine if OJ supplementation attenuates IL-6 or TNF-α levels in 
human skeletal muscle following repeated exercise bouts in the heat. We proposed two hypotheses; first, 
that exercise in a hot humid environment would increase cytokine levels in skeletal muscle and second, 
that supplementation with 100% OJ or a carbohydrate-electrolyte beverage following exercise would 
attenuate increases in cytokines in skeletal muscle in comparison to the control, water. We saw no 
significant difference between time points suggesting that the first hypothesis is not supported by these 
results. However, a significant group x time interaction was seen, supporting our second hypothesis. This 
interaction showed that IL-6 protein levels from individuals in the W increased linearly over the course of 
the study (Days1-11). Further, a significant difference was seen between  OJ and W group Day 8 IL-6 
measures. Meanwhile the OJ and CEB groups saw no such significant differences in IL-6 levels overtime 
and remained relatively the same. This suggests that consumption of supplemental beverages like OJ or 
CEB may attenuate increases in intramuscular IL-6. 
This study also investigated TNF-α but we observed no measurable levels of TNF-α in the muscle samples 
of any of the three groups. These data are in agreement with previous studies showing that TNF-α is not 
necessary to stimulate the release of IL-6 during exercise and is often not detectable after exercise or not 
significantly produced or released from skeletal muscle (A. Steensberg et al., 2002). As mentioned 
previously, skeletal muscle production of IL-6 protein during exercise is separate from the traditional acute 
phase response and is independent of TNF-α stimulation (Munoz-Canoves et al., 2013). In fact, exercise 
and IL-6 injection are known to inhibit endo-toxin induced increases of TNF-α (R. Starkie, Ostrowski, 
Jauffred, Febbraio, & Pedersen, 2003).  
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Ascorbic acid has been suggested to attenuate IL-6 levels (Vassilakopoulos et al., 2003). However, we saw 
no difference between the OJ and CEB groups which is not surprising considering the mixed results of 
research investigating ascorbic acid supplementation. While Fischer et al. (Christian P. Fischer et al., 2004) 
found no significant changes in intramuscular IL-6 after supplementing with ascorbic acid, 
Vassilakopoulos et al. (2003) saw significant attenuation of cytokines post exercise. The latter study used 
high 1000mg/day dosages of ascorbic acid though, much higher the daily-recommended amount of 75-
90mg and the 83.6mg present in the OJ consumed daily in the present study (Medicine, 2000). 
Supplementation with pills is also known to produce higher plasma levels of ascorbic acid  than just a diet 
of high ascorbic acid  foods (Padayatty et al., 2004). Therefore, the amount of ascorbic acid ingested daily 
in this study was not enough to boost antioxidant levels to amounts that would lead to significant 
attenuation of cytokine release.  
The non-significant increases in cytokines post-exercise conflicts with findings from studies with similar 
exercise and environmental protocols (Brenner et al., 1999; Mundel et al., 2010). The non-significant 
difference for time or group could be attributed to the time points at which muscle biopsies were collected. 
Biopsies were taken from subjects pre-exercise on days 1, 4, 8, and 11. Days 4 through 8 were exercise 
days. Maximal IL-6 levels are often observable immediately after exercise and rapidly decrease with a 
half-life of 1-2 hours (B. K. Pedersen, 2000). Ostrowski et al. (1998) reported a decrease in IL-6 proteins 
from their peak measurement immediately post. After 3 hours of cycling at 60% VO2max IL-6 protein in 
muscle biopsies significantly increased, peaking at 6 hours post, but decreasing below significance by 24 
hours post exercise (Ostrowski et al., 1998). The measures taken in the current study occurred nearly 24 
hours post exercise, which would be near a time at which IL-6 levels would be returning to resting values. 
The significant interaction found for the W group and differences between the W and OJ grpups on Day 8 
could be due to the carbohydrates present in the OJ and CEB beverages that are not present in W (Figure 
5). Though it is widely accepted that skeletal muscle is capable of producing IL-6 during exercise it is 
24  
possible that the “leaky gut” theory contributes to inflammation during exercise. If so, the consumption of 
carbohydrates could play a role in decreasing the level of inflammation and cytokine production that result 
from vigorous exercise. 
A more likely mechanism for the attenuation of the IL-6 in the OJ and CEB groups compared to W is the 
addition of carbohydrates. IL-6 is thought to help regulate glucose metabolism during vigorous exercise 
when glycogen stores begin to be depleted (Helge et al., 2003). The presence of IL-6 in cultured rat 
hepatocytes induces glucose release (Ritchie, 1990). After release into the bloodstream, this glucose could 
then be taken up by active muscle for substrate utilization. It has been observed that blood glucose and IL-
6 measures have an inverse relationship (Adam Steensberg et al., 2001) . Carbohydrate ingestion attenuates 
plasma levels of IL-6 post-exercise compared to no carbohydrate consumption, but intramuscular IL-6 
mRNA levels were not significantly affected by carbohydrate supplementation (R. L. Starkie et al., 2001; 
Adam Steensberg et al., 2001). The present study did not investigate gene expression but IL-6 protein 
content showed a greater increase in the W group compared to OJ and CEB. It could be possible that 
carbohydrate ingestion affects IL-6 mRNA translation or release from active skeletal muscle. As it relates 
to the present study, that would suggest that the ingestion of beverages that contain adequate carbohydrates 
like OJ and CEB help replenish glycogen stores thus dampening the increase in cytokine levels. 
Limitations of this study would include the study design, which did not allow for post-exercise muscle 
biopsies that would have led to more insight into the effect that supplementation with these beverages had 
on recovery and cytokine production after cycling in the heat. Other limitations would be the measures 
taken. Perhaps measuring mRNA values or investigating cytokines that appear more readily would have 
provided more data. In order to test the hypotheses of this study further, future research is needed. Ideally 
using repeated bouts of exercise or a training study in which skeletal muscle biopsies are taken pre and 
post exercise would provide more data on IL-6 and TNF-α. Possibly cytokine mRNA and protein measures 
can be compared in order to gain a better sense of the viability of protein measures. 
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In conclusion, there was no main effect for time or group concerning intramuscular IL-6 after repeated 
bouts of aerobic exercise. TNF-α production was not induced in measurable amounts by the exercise 
stimulus in this study. The ascorbic acid content of OJ (83.6mg/8oz) alone may not be enough to negate 
the inflammatory effects of exercise in such a short time period (USDA, 2016). However, there was 
significant group x time effect in which IL-6 increased over time in the W group but did not increase in the 
OJ or CEB groups and a significant difference between the OJ and W groups on Day 8. This data suggests 
that the carbohydrate content of OJ and CEB could attenuate IL-6 increases when compared to a control 
(W). Replenishment of fuel has long been a standard practice post-exercise and its value is understood but 
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Appendix A: Informed Consent 
 INFORMED CONSENT TO PARTICIPATE IN RESEARCH STUDY 
 
Examination of 100% Orange Juice on Rehydration and Recovery following Repeated Endurance 
Exercise 
INTRODUCTION 
The Department of Health, Sport, and Exercise Sciences at the University of Kansas supports the practice 
of protection for human subjects participating in research. The following information is provided for you 
to decide whether you wish to participate in the present study. You may refuse to sign this form and not 
participate in this study. You should be aware that even if you agree to participate, you are free to withdraw 
at any time. If you do withdraw from this study, it will not affect your relationship with this unit, the 
services it may provide to you, or the University of Kansas. 
 
STUDY PURPOSE 
The purpose of this study is to determine how 3 different fluids effect hydration status, muscle recovery, 
and subjective measures in exercising persons. This study is funded by the Florida Department of Citrus. 
 
PROCEDURES 
You are being invited to participate in this study because you are between the ages of 18 and 35 years old, 
complete endurance exercise at least 3 days a week, and are in good general health. If you agree to 
participate, you will be participating with approximately 30 other people. 
 
Study Participation 
After signing the informed consent form, you will complete a Health and Injury History Questionnaire to 
determine inclusion or exclusion into the study. You cannot participate in this study if you have 
cardiovascular, respiratory, metabolic, or bleeding disorders; muscle disorders preventing exercise; fluid 
or electrolyte disorders; and/or gastrointestinal or swallowing disorders. We will take a hydrated weight 
to use as a baseline throughout the data collection. Before inclusion into the study you will complete a 
V̇O2max tests to measure your endurance capacity. If included in the study, you will be randomly assigned 
to complete 1 experimental trial (water, carbohydrate electrolyte beverage, or orange juice). You will be 
unaware of which trial you are completing. The trial will take 11 days. You will be given a beverage to 
drink for each of the 11 days. On 5 days you will exercise for 75 minutes and rest for 1 hour after exercise. 
Total time to complete each exercise day is approximately 3 hours. On 4 days you will have blood and a 
muscle biopsy taken. While participating in the study, we ask that you maintain your normal levels of 
physical activity, avoid changing your caffeine consumption, and avoid drinking alcohol. All exercise 




All beverages will be given in bottles that are covered so you cannot see what is inside. On non-exercise 
days (Days 1-3 and 9-11) you will consume one bottle in the morning. On exercise days (Days 4-8) you 
will consume the beverage after exercising. 
 
Water (W). Each bottle will contain 237 ml (approximately 8 oz or 1 cup) of orange flavored 
 
Carbohydrate-electrolyte beverage (CEB). Each bottle will contain 237 ml (approximately 8 oz or 1 cup) 
of a commonly available CEB. 
 
Orange Juice (OJ). Each bottle will contain 237 ml (approximately 8 oz or 1 cup) of 100% OJ. 
 
Instruments and Protocols 
V̇O2max Test. The V̇O2max test is a graded exercise test to determine aerobic capacity or peak oxygen 
uptake. While cycling on a stationary bike you will wear a mask and a nose clip to collect expired oxygen 
and carbon dioxide. To be included in the study you must have a V̇O2max > 40 ml/kg/min. 
Exercise Protocol. The exercise protocol is designed to induce muscle glycogen depletion and mild 
dehydration. On Days 4-8, participants will perform 80 min of exercise each day. The exercise starts with 
a 2.5 min warm up, then four 15 min periods of cycling at 80% V̇O2max. Each 15 min period is separated 
by 5 min of cycling at a lower intensity. The exercise ends with a 2.5 min cool down. To achieve 1-2% 
dehydration, you will be provided water in the amount of 1.5 ml/kg of body weight every 15 minutes. 
Exercise will be conducted in an environmental chamber set at a mild, thermal temperature (86°F, 50% 
humidity). 
Blood Measures. To obtain blood we will insert a needle into a vein in your arm. On Days 1 and 11 we 
will use one single needle stick to take 2 6 ml tubes (approximately 2.5 tsp). On each of Days 4-8 a single 
needle stick will be done 3 times: before and after exercise and after the 1 hour rest. For each blood draw 
we will take 2 6 ml tubes for a total of 6 tubes (approximately 2.5 Tbsp) a day. The total blood taken on 
Days 4-8 is approximately 12.5 Tbsp, about 1/3rd of what is taken when donating blood. 
We will use blood to measure plasma osmolality, electrolytes (sodium, potassium, calcium, and chloride), 
inflammatory markers (cytokines and C-reactive protein), muscle damage (phosphocreatine kinase), and 
oxidative stress. 
Urine Measures. On exercise days urine will be used to determine hydration status. You will use a private 
restroom to collect the urine sample. Using a urine cup, you will provide 1 sample upon arriving to the 
laboratory and one sample after exercise. During the 1 hour rest period you will collect urine into a urine 
container to measure volume. The cup will be labeled with your participant number. We will measure 
urine for specific gravity and osmolality. 
Body Weight. A body composition scale will be used to determine your nude weight to characterize 
hydration. Once you arrive to the laboratory, you will be asked to void all urine. The scale will be set up 
in a private area where you will be asked to remove all clothing and step on the scale. A second body 
weight will be taken immediately after exercise and after the 1 hour rest. 
Muscle Biopsies. Four skeletal muscle biopsies will be taken during this study (on days 1, 4, 8, and 11). 
Each muscle sample (approximately the size of a pea or ~100 mg) will be obtained from the lateral aspect 
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of your thigh using the percutaneous needle biopsy technique. The biopsies will be performed on alternate 
legs (ie, right leg for day 1 and 8, and left leg for day 4 and 11). The procedure is overseen by Jeff Burns, 
M.D., who is a medical doctor in Neurology at the KU Medical Center in Kansas City, Kansas. Dr. Burns 
supervises the procedure, but will not be physically present for the biopsies. Each biopsy should take 
approximately 20 minutes. 
For the biopsy procedure, the following will occur: 
1. You will be placed on an examination table lying down on your back (supine). 
2. Your skin will be thoroughly cleaned with antiseptic solution (Betadine) around the sampling site. 
If you are allergic to Betadine, an alternative antiseptic solution will be used to clean the skin. 
3. A small amount (3 ml or 3 cc) of a local anesthetic (2% Lidocaine) will be injected into the tissue 
under the skin around the site to be sampled. If you are allergic to the local anesthetic, or have had 
allergic reactions to other anesthetics (ie, Novocain) then you will be disqualified from the study. 
4. Following a minimum of 5 minutes to ensure adequate time for the agent to take effect, a small 
incision (1 cm) will then be made in the skin and the biopsy needle inserted into the middle of the 
muscle (muscle belly) at a depth of 3 cm (about 1 inch). During this time that the sample is being 
taken (about 5 seconds) you may feel some deep pressure and cramping that will be moderately 
painful. 
5. Following the biopsy procedure, firm and constant pressure will be placed on the wound to stop 
the bleeding. The incision site will be closed with a steri-strip, covered with a large Band-Aid and 
the site compressed using a 10 cm stirp of sterile elastic foam tape for a 24 hr period. 
Thirst. On exercise days we measure your perceived thirst using a 9-point scale. The scale ranges from 1 
(not thirsty at all) to 5 (moderately thirst) to 9 (very, very thirsty). You will be asked to rate your thirst 
pre- and 15, 30, 45, and 60 minutes post drinking your assigned beverage. 
Palatability. Palatability will also be measured immediately after drinking the beverage. This 
questionnaire uses a 9-point scale, ranging from 1 (dislike extremely) to 5 (neither like nor dislike) to 9 
(like extremely). Questions include overall beverage, flavor, sweetness, saltiness, and tartness. 
Gastrointestinal Symptom Index. Gastrointestinal discomfort will be measured before exercise, every 15 
minutes during exercise, immediately after exercise, and 1 hour after exercise. Questions include upper 
abdominal problems (belching, reflux, bloating, etc.), lower abdominal problems (cramping, diarrhea, 
pain, etc.), and systemic problems (dizziness, headache, etc.). 
Profile of Mood States. This questionnaire measures your mood disturbance and is taken by computer 
online. There are 35 items on a 5-point scale (0 = not at all to 4 = extremely) related to feelings of anger, 
hostility, confusion, bewilderment, depression, dejection, fatigue, inertia, tension, anxiety, vigor, and 
activity. You will complete this questionnaire on the first and last days of the trial as well as before and 
after exercise. 
Rate of Perceived Exertion (RPE). The Borg Scale is used to measure your RPE before, every 15 minutes 
during, and immediately after exercise. 
Cardiovascular. To ensure you remain at safe limits and determine effects on cardiovascular function, 
your heart rate will be continuously monitored during exercise using a strap worn around your chest. In 
addition, blood pressure will be measured every 15 minutes during exercise. 
Core Temperature. To assess thermoregulatory strain and ensure you remain at safe limits, core 
temperature is recorded continuously throughout exercise using a rectal temperature probe. You will be 
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asked to insert the flexible probe ~ 4 inches (10 cm). Appendix A includes additional information on the 
rectal temperature probe. You will not be allowed to exceed a core temperature greater than 104°F and we 
will monitor your temperature after exercise until you return to your normal temperature. 
Diet and Physical Activity. On each day of the trial you are asked to complete a diet and activity log. We 
ask that you maintain similar diet and activity habits during the 11 days, but that you avoid orange juice 
and other citrus food and beverages. We ask you to avoid alcohol during the trial. We also ask that you do 
not complete strenuous activity at least 2 days before the start of your trial and that you do not complete 
additional exercise outside the trial or take any anti-inflammatory or pain medications (for example, Aleve, 
Tylenol, aspirin, etc). 
 
Procedures 
Data Collection (Figure 1). You will report Day 1 for baseline testing which includes a blood draw, 
muscle biopsy, and completing the profile of mood states (POMS) survey. We will provide you with Take 
Home Instructions and 3 bottles containing 8 oz (237 ml) each of your assigned beverage. You will 
consume 1 bottle on Days 1-3. Before arriving for each exercise day (Days 4-8), you should eat a small 
meal and drink at least 8 oz of water. Before beginning the exercise protocol you must be hydrated. Urine, 
body weight and all survey measures are taken before exercise, after exercise, and 1 hour after exercise. 
Blood measures and muscle biopsies are taken on Days 4 and 8. Gastrointestinal discomfort symptoms, 
RPE, heart rate, blood pressure, and core temperature will be assessed during exercise. Once you finish 
exercise you will be given 1 bottle with 8 oz of your assigned beverage to drink. Immediately after drinking 
your beverage you will complete the palatability survey. You will rest for 1 hour in an ambient 
environment. During the 1 hour you will complete the thirst survey. Prior to leaving the laboratory on Day 
8 (final exercise day), we will give you Take Home Instructions and 3 bottles containing 8 oz each of your 




You may experience one or more of the risks indicated from being in the study. In addition to these, there 
may be other unknown risks, or risks we did not anticipate, associated with participation in this study. 
The following risks may occur due to the muscle biopsy: 
1. The local anesthetic will result in a slight burning sensation, lasting approximately 5 seconds. 
2. There is an extremely low risk of allergic reaction to the local injection (1 in 1 million). 
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3. Nausea, dizziness, and fainting can occur in remote cases (1 in 100) 
4. There is a minimal risk of infection (1 in 1,000) and irritation. The use of aseptic techniques, 
careful cleaning of the skin, and keeping the area dry will minimize the risk of infection. 
5. There is a minimal risk of bruising (1 in 100). Applying a compression bandage on the muscle 
biopsy site for 24 hrs following will minimize bruising. 
6. In rare instances (1 in 200), some motor nerves may be damaged which may cause local muscle 
atrophy (decrease in the size of muscle fibers, with a small dimple on the skin). 
7. There is likely to be a small scar (1/2 inch in length) where the incision for the muscle biopsy is 
performed. The scare usually dissipates over a period of 6-12 months at which time the scaring is 
very modest. 
The following risks may occur due to the blood draw: 
1. It is likely to experience mild pain or discomfort when having blood drawn, although we do not 
anticipate additional blood draws than what is require for normal treatment of care. 
2. Bruising at the site in your arm where the needle is inserted is less likely/common to occur. 
3. In rare cases you may develop a hematoma (localized swelling filled with blood) at the site in your 
arm where the needle was inserted. 
All beverages are FDA approved and ingredient amounts are minimal. You may experience any of the 
following minimal risks associated with ingredients used to preserve and sweeten beverages: 
 
Ingredient Potential risks 
Acesulfame potassium Cancer from long-term use 
Calcium disodium EDTA Reduce antibiotic medication effects; if taken in excessive amounts low 
blood sugar, low blood pressure, kidney failure, and seizures 
Calcium chloride Irritation of nostrils, mouth, throat, lips, eyelids, and ears; gastrointestinal 
discomfort 
Citric acid/sodium citrate Allergic reactions; gastrointestinal discomfort; increase urine volume 
Dextrose Weight gain, diabetes, cardiovascular disease, certain cancers, and lowered 
immunity 
Gum acacia Allergic reactions; increased cholesterol; gastrointestinal distress 
Glycerol ester of rosin Allergic reactions 
Magnesium sulfate Thirst, gastrointestinal discomfort, and allergic reactions 
Magnesium chloride Allergic reactions; diarrhea 
Monopotassium 
phosphate 
Allergic reactions; kidney and cardiovascular dysfunction 
Niacin Allergic reactions; gastrointestinal discomfort; flu like symptoms 
Potassium benzoate Mild irritation to skin, eyes, and mucus membranes; in some beverages 
converts to benzene (a carcinogen) 
Potassium sorbate Allergic reactions; nasal congestion; and gastrointestinal discomfort 
Sodium benzoate Increase hyperactivity in individuals with attention deficit disorder 
Sodium phosphate Gastrointestinal discomfort and allergic reactions 
Sucralose Weight gain and diabetes 
Vitamin A Dizziness, headache, nausea, skin irritation, liver damage, and joint/bone 
pain with chronic excess use 
Vitamin B3 (niacin) Allergic reactions; gastrointestinal discomfort; flu like symptoms 
Vitamin B6 Gastrointestinal discomfort; brain and nerve problems with long-term use 
Vitamin B12 Allergic reactions; gastrointestinal distress 
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Vitamin C (ascorbic 
acid) 
Extremely high doses may cause redness, warmth, or flushing of skin; 
headache; gastrointestinal discomfort 
Vitamin E Complicate existing cardiovascular disease or diabetes 
Yellow 5 Allergic reactions; negative interaction with aspirin and aspirin 
hypersensitive individuals 




As a result of participating in this study you will be provided your V̇O2max. We will also calculate and 
provide you your sweat rate during exercise by using your body weight and fluid consumed. 
 
PAYMENT TO PARTICIPANTS 
Participants will receive $25 for completing Days 1-4, $75 for completing Days 5-8, and $100 for 
completing Days 9-11. Investigators will ask for your social security number in order to comply with 
federal and state tax and accounting regulations. 
 
PARTICIPANT CONFIDENTIALITY 
Your name or any other identifiable information will not be associated in any publication or presentation. 
All information collected about you or with the research findings from this study will be coded with a 
study number. Only the primary investigators will have access to documents with your identifiable 
information and documents will be kept in a locked cabinet in a locked office. No identifiable information 
about you will be shared unless (a) it is required by law or university policy, or (b) you give written 
permission. 
 
REFUSAL TO SIGN CONSENT AND AUTHORIZATION 
You are not required to sign this Consent and Authorization form and you may refuse to do so without 
affecting your right to any services you are receiving or may receive from the University of Kansas or to 
participate in any programs or events of the University of Kansas. However, if you refuse to sign, you 
cannot participate in this study. 
 
CANCELLING THIS CONSENT AND AUTHORIZATION 
You may withdraw your consent to participate in this study at any time. You also have the right to cancel 
your permission to use and disclose further information collected about you, in writing, at any time, by 
sending your written request to: Dawn Emerson or Philip Gallagher (contact information below). If you 
cancel permission to use your information, the researchers will stop collecting additional information 
about you. However, the research team may use and disclose information that was gathered before they 
received your cancellation, as described above. 
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QUESTIONS ABOUT PARTICIPATION 
Questions about procedures should be directed to the researchers listed at the end of this consent form. 
PARTICIPANT CERTIFICATION 
I have read this Consent and Authorization form. I had the opportunity to ask and I received answers to 
any questions I had regarding the study. I understand that if I have any additional questions about my 
rights as a research participant, I may call (785) 864-7429 or (785) 864-7385, or write the Human Subjects 
Committee Lawrence Campus (HSCL), University of Kansas, 2385 Irving Hill Road, Lawrence, Kansas 
66045-7568, or email irb@ku.edu. 
 
I agree to take part in this study as a research participant. By my signature I affirm that I am at least 18 
years old and that I have received a copy of this Consent and Authorization form. 
 
 





RESEARCHER CONTACT INFORMATION 
Dawn M. Emerson, PhD, ATC 
Principal Investigator 
Department of Health, Sport, and Exercise 
Sciences 
Robinson Center, Room 101E 
University of Kansas 




Philip Gallagher, PhD 
Principal Investigator 
Department of Health, Sport, and Exercise 
Sciences 
Robinson Center, Room 101DJ 
University of Kansas 





Melani Kelly, MS, ATC 
Co-Investigator 










RECTAL TEMPERATURE ASSESSMENT 
 
The picture to the right shows the 
temperature monitor and flexible probe. 
The probe is approximately 0.1 inches (3 
mm) in diameter. The entire probe length is 
3 feet. You will insert the probe 
~ 4 inches, about where the black arrow indicates. 
 
The probe will remain in place throughout 
the biking with the monitor resting nearby, 
similar to the picture below. 
 
 
To insert the rectal probe: 
1. You will be given a clean probe with a piece of tape to indicate the 4 inch mark. 
2. You will go to a private bathroom. 
3. The probe should be inserted 4 inches past the anal sphincter. This is best done with one 
knee and hip slightly flexed forward. You should also try to relax as much as possible. 
4. If you meet resistance, stop, remove the probe and try again. 
 
To remove: 
5. Once your core temperature returns to normal during the rest period, you may go to the 
bathroom and remove the probe. To remove, simply pull the probe out gently. 
6. Wipe the probe off with tissue and discard the tissue. 
7. Return the probe to a research assistant. 
 
There are no known serious risks associated with using the rectal temperature probe. You may 







Appendix B: Health History Questionnaire 
HEALTH AND HEALTH AND INJURY HISTORY QUESTIONNAIRE 
INSTRUCTIONS:  Complete the following questions the best of your knowledge/ability. Let the 
investigator know if you need further explanation. 
Part 1.  Participant Information 
Name: ________________________   Age: _______    Participant #: 
____________  
Part 2. Physical Activity Readiness Questionnaire© (Canadian Society for Exercise Physiology) 
            
 Yes No 
1. Has your doctor ever said that you have a heart condition and that you should only do   
   
physical activity recommended by a doctor? 
2. Do you lose your balance because of dizziness or do you ever lose consciousness?       
3. Is your doctor currently prescribing drugs (for example, water pills) for blood       
pressure or a heart condition? 
Part 3.  Medical History Explain “yes” answers below. (American Medical Society for Sports Medicine, 
American Orthopedic Society for Sports Medicine, American Heart Association, and American College of Sports 
Medicine) 
            
 Yes No 
1. Have you had a medical illness or injury since your last check up or sports physical? 
     
2. Do you have an ongoing chronic illness?       
     
3. Have you ever passed out during or after exercise?      
     
4. Have you ever been dizzy or fainted during or after exercise?     
     
5. Have you ever had pain, discomfort, tightness, or pressure in your chest during  
     
or after exercise? 
6. Have you ever had racing of your heart or skipped heartbeats?    
     
7. Have you had high blood pressure or high cholesterol?     
     
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8. Have you ever been told you have a heart murmur?     
     
9. Has a physician ever denied or restricted your participation for sports or for any heart 
     
 problems?       
10. Have you ever had an unexplained seizure?      
     
11. Have you ever had numbness or tingling in your arms, hands, legs, or feet? 
     
12. Have you ever become ill from exercising in the heat?     
     
13. Do you cough, wheeze, or have trouble breathing during or after activity?   
     
14. Do you have diabetes?          
     
15. Do you have asthma or other lung disease?       
     
16. Do you smoke?          
     
17. Do you have or think you may have any bleeding disorders?     
     
18. Do you have, or think you may have, any of the following conditions?  Check all that apply. 
___   Nausea, vomiting, or other gastrointestinal disorders 
___   Obstructive disease of the gastrointestinal tract, such as diverticulitis or inflammatory 
bowel disease 
___   A history of disorders or impairment swallowing or of the gag reflex 
___   Any gastrointestinal surgery 
 







20. Do you get frequent muscle cramps when exercising?      
   Yes   No 
21. Do you or someone in your family have sickle cell trait or disease?   
   Yes   No 
22. Have you ever experienced an exertional heat stroke or other significant heat illness? 
   Yes   No 
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23. Are you allergic to any medications?        
   Yes   No 
 





24. Are you currently taking any prescription medications, pills, or an inhaler?   
   Yes   No 
 For example: Albuterol, Prednisone, Naproxen, etc. 





25. Are you currently and regularly taking any non-prescription (over-the-counter)  
   Yes   No 
medications or pills? For example: Bayer, Prilosec, NyQuil, etc.    





26. Are you currently and regularly taking any vitamins, supplements, or other substances? 
   Yes   No  
For example: multi-vitamin, iron, diet pills, energy drinks, protein powder, etc.   
   






27. Is your menstrual cycle regular?         
    Yes    No 
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28. Are you on birth control?         
    Yes    No 
29. Are you currently on your period?       
    Yes    No 
30. What is the date of your last period? ____________________ 
 
I hereby state that, to the best of my knowledge, my answers to the above questions are complete 
and correct. 
 
__________________________ _____________________________     
 __________________  
Signature of Participant   Printed Name of Participant        Date 
